Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07481682Completed
Trial of tranexamic acid in pulmonary hemorrhage (2 arms), sponsored by Tanta University. Primary endpoints: Cessation of pulmonary hemorrhage at 48 hours and Incidence of adverse effects at 48 hours. Started Aug 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07481682.